SPI

SPI handeln
18.684,24 PKT +101,75 PKT +0,55 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 998750

ISIN CH0009987501


Analysen zu SPI-Werten

Datum Rating Analyst
25.04.19 UBS overweight JP Morgan Chase & Co.
25.04.19 UBS Hold Deutsche Bank AG
25.04.19 Novartis Underweight JP Morgan Chase & Co.
24.04.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
24.04.19 Nestlé buy Baader Bank
24.04.19 Novartis Neutral UBS AG
24.04.19 Holcim overweight Morgan Stanley
24.04.19 UBS buy UBS AG
24.04.19 Alcon buy Goldman Sachs Group Inc.
24.04.19 UBS Neutral JP Morgan Chase & Co.
24.04.19 Novartis Underweight JP Morgan Chase & Co.
24.04.19 Nestlé buy UBS AG
24.04.19 UBS buy Goldman Sachs Group Inc.
24.04.19 Nestlé buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
24.04.19 UBS Equal-Weight Morgan Stanley
24.04.19 UBS Sector Perform RBC Capital Markets
23.04.19 Holcim Outperform Credit Suisse Group
23.04.19 UBS Equal weight Barclays Capital
23.04.19 Nestlé buy Goldman Sachs Group Inc.
23.04.19 Swiss Re Outperform Credit Suisse Group
19.04.19 Nestlé Underperform Credit Suisse Group
18.04.19 Alcon Market Perform BMO Capital Markets
18.04.19 Nestlé Sector Perform RBC Capital Markets
18.04.19 Nestlé overweight JP Morgan Chase & Co.
18.04.19 ABB (Asea Brown Boveri) buy Kepler Cheuvreux
18.04.19 Roche buy Jefferies & Company Inc.
18.04.19 Nestlé buy Goldman Sachs Group Inc.
18.04.19 Nestlé buy Jefferies & Company Inc.
18.04.19 Nestlé buy Baader Bank
18.04.19 Nestlé buy Deutsche Bank AG
18.04.19 Nestlé market-perform Bernstein Research
18.04.19 Nestlé overweight JP Morgan Chase & Co.
18.04.19 Holcim overweight JP Morgan Chase & Co.
18.04.19 Roche Neutral Credit Suisse Group
18.04.19 ABB (Asea Brown Boveri) buy Deutsche Bank AG
18.04.19 Roche Hold Deutsche Bank AG
17.04.19 Roche buy Goldman Sachs Group Inc.
17.04.19 Roche Hold Kepler Cheuvreux
17.04.19 Zurich Insurance Neutral JP Morgan Chase & Co.
17.04.19 Novartis Underweight JP Morgan Chase & Co.